AstraZeneca said that its vaccine developed with the University of Oxford appeared to offer limited protection against mild disease caused by the South African variant of COVID-19
#News #CovidVaccine #AstraZeneca
Subscribe:…
AstraZeneca said that its vaccine developed with the University of Oxford appeared to offer limited protection against mild disease caused by the South African variant of COVID-19
#News #CovidVaccine #AstraZeneca
Subscribe:…